Our findings provide a well-characterized mechanism underlying which AngII stimulates mitochondrial fission and consequent apoptosis, which may offer a new therapeutic strategy for treating hypertension-induced heart failure via the Sirt1-p53-Drp1 pathway. This evidence concerns the gene TP53 and hypertensive disorder.